| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.058 | 0.3 |